NurExone Biologic Inc.
NRX.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -16.00% | -72.26% | 5.79% | -26.73% | 501.66% |
| Total Receivables | 6.30% | -50.97% | -27.65% | -8.21% | 297.96% |
| Inventory | 0.00% | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 0.00% | 0.00% | 28.13% | -97.40% |
| Total Current Assets | -16.52% | -42.12% | 1.40% | -24.29% | 85.52% |
|
|
|||||
| Total Current Assets | -16.52% | -42.12% | 1.40% | -24.29% | 85.52% |
| Net Property, Plant & Equipment | -3.84% | 2.02% | 55.71% | 9.25% | 147.34% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -12.33% | -32.46% | 9.78% | -20.52% | 90.88% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | -44.84% | 97.09% | -0.58% | -25.11% | -57.85% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 542.11% | -78.33% | -29.49% | 184.73% | -9.66% |
| Total Other Current Liabilities | 542.11% | -78.33% | -29.49% | 184.73% | -9.66% |
| Total Current Liabilities | 38.94% | -8.51% | -20.33% | 50.83% | -81.03% |
|
|
|||||
| Total Current Liabilities | 38.94% | -8.51% | -20.33% | 50.83% | -81.03% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 0.00% | 0.00% | 24.00% | 4.17% | 1,100.00% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -4.38% | 14.09% | 50.68% | 16.80% | 76.06% |
| Total Liabilities | 21.18% | -0.87% | -4.32% | 40.31% | -74.20% |
|
|
|||||
| Common Stock & APIC | 15.86% | -0.92% | 5.68% | 2.01% | 35.64% |
| Retained Earnings | -8.79% | -8.81% | -7.67% | -8.85% | -6.56% |
| Treasury Stock & Other | -48.15% | 20.12% | 31.59% | -2.93% | 1.39% |
| Total Common Equity | -25.27% | -39.86% | 13.71% | -29.08% | 1,821.16% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -25.27% | -39.86% | 13.71% | -29.08% | 1,821.16% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -25.27% | -39.86% | 13.71% | -29.08% | 1,821.16% |
|
|
|||||